Latest Articles

Publication Date
Real world perspectives on endometriosis disease phenotyping through surgery, omics, health data, and artificial intelligence.

Endometriosis is an enigmatic disease whose diagnosis and management are being transformed through innovative surgical, molecular, and computational technologies. Integrating single-cell and other omic disease data with clinical and surgical …

Published: Feb. 6, 2025, midnight
Cine-MRI for Quantifying Uterine Peristalsis: A Systematic Review and Meta-Analysis.

Background: Uterine contractility, also known as uterine peristalsis (UP), is a critical determinant of fertility, affecting sperm transport and embryo implantation. Increased uterine peristaltic activity has been associated with reduced …

Published: Feb. 6, 2025, midnight
The impact of MTHFR and VDR polymorphisms on endometriosis susceptibility: Insights from a systematic review and meta-analysis.

The VDR and MTHFR polymorphisms have been linked to many gynecological and obstetrical diseases. However, there is still a pressing need for a systematic review and meta-analysis to synthesize the …

Published: Feb. 6, 2025, midnight
Remakes 2025: Films and tv shows getting remade - The Australian Women's Weekly

Remakes 2025: Films and tv shows getting remade The Australian Women's Weekly

Published: Feb. 5, 2025, 11:12 p.m.
ASCO Reading Room | Is the End of Systemic Chemotherapy Near for Advanced Endometrial Cancer? - Medpage Today

ASCO Reading Room | Is the End of Systemic Chemotherapy Near for Advanced Endometrial Cancer? Medpage Today

Published: Feb. 5, 2025, 7:31 p.m.
Christian Marth on a First-Line Chemotherapy-Free Option for Advanced Endometrial Cancer - Medpage Today

Christian Marth on a First-Line Chemotherapy-Free Option for Advanced Endometrial Cancer Medpage Today

Published: Feb. 5, 2025, 5:54 p.m.
First-Line Lenvatinib Plus Pembrolizumab Versus Chemotherapy for Advanced Endometrial Cancer: A Randomized, Open-Label, Phase III Trial - Medpage Today

First-Line Lenvatinib Plus Pembrolizumab Versus Chemotherapy for Advanced Endometrial Cancer: A Randomized, Open-Label, Phase III Trial Medpage Today

Published: Feb. 5, 2025, 5:54 p.m.
Serac Healthcare Advances Non-Invasive Endometriosis Imaging Test Following FDA Meeting - Femtech Insider

Serac Healthcare Advances Non-Invasive Endometriosis Imaging Test Following FDA Meeting Femtech Insider

Published: Feb. 5, 2025, 12:02 p.m.
Endometriosis, Lyv Healthcare raises 2.6 million euros to impose e-health in the management of chronic female diseases - Businesslife.co

Endometriosis, Lyv Healthcare raises 2.6 million euros to impose e-health in the management of chronic female diseases Businesslife.co

Published: Feb. 5, 2025, 3:32 a.m.
US tennis star Danielle Collins postpones retirement and will return to WTA Tour in 2025 - AOL

US tennis star Danielle Collins postpones retirement and will return to WTA Tour in 2025 AOL

Published: Feb. 5, 2025, 3:28 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!